Skip to main content
Caplight Logo









HeMemics Biotechnologies

HeMemics Biotechnologies

Private
Gaithersburg, MarylandHealthcare & Life Scienceshttps://www.hememics.com/

Last Round

VC Round

Mar 19, 2025

Total Funding Raised

$5.26M

Company Overview

HeMemics Biotechnologies is a biotechnology company that develops a handheld, graphene-based biosensor platform for simultaneous testing of antibodies, antigens, and molecular targets.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Sensors, Defense Tech, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsbiosensor platformgraphene biochipsmultiplexed testinglab-on-a-chipportable diagnostic devicebiodefenserazor-and-blade modelfield diagnosticsreagent stabilizationmedical devicePOC testingrapid diagnosticsbiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HeMemics Biotechnologies Comparables

Compare HeMemics Biotechnologies with similar companies based on industry and business-model similarity.

HeMemics Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IdentifySensors Biologics
83%
Sapphiros
81%
GRIP Molecular Technologies
78%

HeMemics Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 19, 2025
GrantJun 7, 2023
SeedMay 25, 2023
SeedDec 11, 2019
GrantJan 31, 2008

Key People

Founding team and executive leadership

John L. Warden

CEO, COO

Executive Team

HeMemics Biotechnologies Investors

Notable investors and investment history

HeMemics Biotechnologies investors
InvestorRounds
NIH RADxGrant
TEDCOGrant, Seed, VC Round
Inova Strategic InvestmentsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2025

    $250K round led by TEDCO

  • May 25, 2023

    $2M round led by TEDCO.

HeMemics Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HeMemics Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HeMemics Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersGaithersburg, Maryland
Employee Range13
Year Founded2009
Last FundingMar 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?